Tennessee Oncology
Tennessee Oncology is a private community-based cancer care provider operating 35+ clinics across Tennessee and North Georgia, delivering medical, radiation, and surgical oncology plus infusion, imaging, proton therapy, clinical trials, and survivorship services to cancer patients.
- Company typePrivate
- Founded1976
- HeadquartersNashville, United States
- Headcount1,001–5,000
- GTM typeB2C
- OfferingServices
What Tennessee Oncology does
Tennessee Oncology is a private, for-profit community-based cancer care provider founded in 1976 and headquartered in Nashville, Tennessee. It operates 35+ clinic locations across Tennessee and North Georgia, delivering a full-spectrum oncology platform that includes medical oncology, hematology, radiation oncology (including a proton therapy center), gynecologic oncology, imaging, infusion therapy, cellular therapy (including CAR-T), and an early-phase clinical research unit. Supporting services span Park Pharmacy (specialty oncology pharmacy), genetic counseling, integrative oncology, palliative care, psychosocial oncology, survivorship care, and financial counseling.
The practice is affiliated with OneOncology, a national partnership of independent community oncology practices, and houses the McKay Institute for Oncology Transformation and the Greco-Hainsworth Centers for Research as innovation and clinical-research arms. It also holds a minority equity stake in OncoveryCare, with which it has expanded a survivorship-care program to all 35 clinics. The practice has begun deploying third-party AI tools — including ambient clinical-documentation scribes, automated fax processing, and Reimagine Care's "Remi" autonomous care assistant — and was an early adopter of CMS's Medicare digital health record system.
Revenue is generated primarily through fee-for-service billing to Medicare, Medicaid, and private insurance payers for clinical services, supplemented by clinical trial participation, specialty pharmacy revenue, and ancillary services. Patient access flows through physician referrals, insurance networks, and direct self-referral across the regional clinic footprint.
Tennessee Oncology firmographics
Firmographics- Name
- Tennessee Oncology
- Legal name
- Tennessee Oncology
- Website
- https://tnoncology.com
- Company type
- Private
- Founded year
- 1976
- Operating status
- Operating
- Headcount range
- 1,001–5,000 employees
- Short description
- Tennessee Oncology is a private community-based cancer care provider operating 35+ clinics across Tennessee and North Georgia, delivering medical, radiation, and surgical oncology plus infusion, imaging, proton therapy, clinical trials, and survivorship services to cancer patients.
- Ownership category
- akta.pro rank
Tennessee Oncology industry classification
Industry- Product category
- Oncology Care Services
- NAICS
- Offices of Physicians (62111), Other Outpatient Care Centers (62149)
- SIC
- Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Specialty Outpatient Facilities, Nec (8093)
- akta.pro primary industry
- Medical Oncology (HLAKAFAB)
- akta.pro secondary industries
- Radiation Oncology (HLAKAFAC), Gynecologic Oncology (HLAKAFAF), Surgical Oncology (HLAKAFAG), Oncology Specialty Pharmaceuticals (HLAIACAA)
Keywords
Where Tennessee Oncology is headquartered
LocationHeadquarters
- HQ city
- Nashville
- HQ country
- United States
- HQ region
- North America
Offices34 records
Markets served
Tennessee Oncology business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales
Revenue model
- Cancer Care Services: Provides comprehensive cancer care services including medical oncology, hematology, radiation oncology, gynecologic oncology, imaging, and infusion therapy through its network of clinics. Revenue is generated through patient services billed to Medicare, Medicaid, and private insurance payers.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Pay-as-you-go | Insurance-based healthcare services |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels4 records
Tennessee Oncology product offering
Product offeringCore offering
Tennessee Oncology is a community-based cancer care practice that provides comprehensive cancer treatment and supportive services across 35+ clinic locations in Tennessee and North Georgia. Its offerings span medical oncology, hematology, radiation oncology, gynecologic oncology, cellular therapy, proton therapy, infusion therapy, diagnostic imaging, early-phase clinical trials, and ancillary support services such as genetic counseling, palliative care, psychosocial oncology, survivorship care, and on-site specialty pharmacy.
Product overview
Tennessee Oncology operates as a comprehensive, multi-module cancer care platform comprising one of the nation's largest community-based oncology networks with 35+ clinic locations across Tennessee and North Georgia. The platform centers on core cancer treatment services (Medical Oncology, Radiation Oncology, Hematology, Gynecologic Oncology) enhanced by specialized treatment centers including a Proton Therapy Center, Cellular Therapy program, and Drug Development Unit for early-phase clinical trials. The offering is augmented by integrated support services (Park Pharmacy, Genetic Counseling, Integrative Oncology, Palliative Care, Psychosocial Oncology, Survivorship Care, Financial Counseling) and sub-branded specialty centers (Nashville Breast Center, Women's Health Center, The Surgical Clinic, Center for Blood Cancers). Digital patient engagement is facilitated through Noona and Navigating Care patient portals. The platform also includes research institutes (Greco-Hainsworth Centers for Research, McKay Institute for Oncology Transformation) that drive clinical innovation and trial development.
Differentiator
Problem solved
Functional benefit
Brands
- The Surgical Clinic: Surgical services offered within the Tennessee Oncology network
- Nashville Breast Center
- Women's Health Center
- McKay Institute for Oncology Transformation
- Greco-Hainsworth Centers for Research
- Park Pharmacy
- Proton Center
Products and services
- Medical Oncology Drug-based cancer treatment including chemotherapy and immunotherapy delivered by oncologists across the Tennessee Oncology clinic network; serves adult cancer patients.
- Radiation Oncology Radiation therapy services including external beam radiation delivered across multiple radiation oncology centers in Tennessee; serves cancer patients requiring radiotherapy.
- Hematology Specialized treatment for blood cancers and blood disorders including leukemia, lymphoma, and myeloma; serves patients with hematologic malignancies and disorders.
- Gynecologic Oncology Specialized cancer care for women's reproductive cancers, including ovarian, cervical, and uterine cancers, delivered through the Women's Health Center locations.
- Cellular Therapy Advanced cellular-based cancer treatments including CAR-T cell therapy for eligible patients.
- Proton Therapy Specialized proton beam radiation therapy delivered from the Proton Center in Franklin, TN, for precise cancer treatment.
- Infusion Therapy Outpatient infusion services for chemotherapy, immunotherapy, and other intravenous cancer treatments delivered at multiple locations.
- Imaging Services Diagnostic imaging including PET scans and radiology services for cancer diagnosis, staging, and treatment monitoring.
- Clinical Trials / Drug Development Unit Early-phase clinical research unit providing cancer patients access to innovative therapies and investigational cancer treatments through clinical trials.
- Park Pharmacy (Specialty Pharmacy) On-site specialty pharmacy providing prescription assistance and medication management services for cancer patients, staffed by dedicated pharmacists.
- Survivorship Care
Quantifiable outcome
- Expanded survivorship care services to all solid tumor survivors across 35 clinic network
Companies that use Tennessee Oncology
Customer profileNamed customers2 records
Segments1 record
Ideal customer profiles1 record
Tennessee Oncology technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability2 records
Feature3 records
Tennessee Oncology partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered core and minor.
- OncoveryCarecoreTennessee Oncology and OncoveryCare expanded their partnership to offer survivorship care to all solid tumor survivors across Tennessee Oncology's network of 35 clinics in Tennessee and North Georgia. The expansion builds on a 2024 partnership that generated thousands of patient visits, addressing the growing US cancer survivor population projected to double to 22 million by 2030. Tennessee Oncology's McKay Institute for Oncology Transformation previously participated in OncoveryCare's seed financing in 2024.
- Sarah Cannon Research InstitutecoreSarah Cannon Research Institute is referenced as a key collaborator in lung cancer research and treatment, with Dr. David Spigel highlighted as a speaker at Lung Cancer Research Foundation events.
- OneOncologycoreTennessee Oncology is affiliated with OneOncology, a partnership of independent community oncology practices focused on advancing cancer care through clinical innovation and practice excellence.
- The Surgical ClinicminorThe Surgical Clinic operates multiple locations within Tennessee Oncology's network, providing surgical oncology services as part of integrated cancer care delivery.
- CMS (Centers for Medicare & Medicaid Services)coreTennessee Oncology is one of three early-adopter practices for Medicare's digital health record system, working with CMS to enable Medicare enrollees to export and share their medical records through a mobile app with QR code functionality.
Scale indicators4 records
Recent moves9 records
Expansion highlights6 records
Tennessee Oncology competitors and assessment
Company assessmentDirect peers
- Florida Cancer Specialists & Research Institute: One of the largest independent, community-based oncology practices in the U.S., offering medical oncology, hematology, radiation oncology, and clinical trials across a multi-state footprint. Highly comparable to Tennessee Oncology in scale, specialty breadth, and community-based delivery model.
- OneOncology: Partnership platform of independent community oncology practices of which Tennessee Oncology is an affiliate. Provides technology, payer contracting, and practice management services — both a strategic ally and a structural benchmark for peer practice performance.
- Sarah Cannon Research Institute: Cancer research and clinical trials organization referenced as a key collaborator in Tennessee Oncology's lung cancer research and treatment. Operates early-phase clinical research units at community oncology sites comparable to Tennessee Oncology's Drug Development Unit.
- Highlands Oncology Group: Community-based multi-specialty oncology practice referenced alongside Tennessee Oncology as a Canopy AI phone-operator deployment site. Comparable in community-based, AI-forward, multi-site oncology delivery.
- Compass Oncology: Independent community oncology practice operating across multiple sites in Oregon and Washington. Comparable in physician-led, multi-clinic community oncology delivery model with integrated imaging, infusion, and clinical trials.
- New York Cancer & Blood Specialists: Large independent community oncology practice in the Northeast offering medical oncology, hematology, radiation oncology, and clinical trials. Similar in scale and multi-specialty community delivery to Tennessee Oncology.
Broad incumbents
- The US Oncology Network (McKesson): The largest network of community-based oncology practices in the U.S., now part of McKesson. Tennessee Oncology's affiliation with OneOncology (itself a community oncology partnership) places it in the same competitive orbit, with overlapping payer negotiations and clinical trial access.
- Vanderbilt-Ingram Cancer Center: NCI-designated academic cancer center located in Nashville, Tennessee. Represents the most direct academic-medical-center competitor for complex oncology cases in Tennessee Oncology's home market.
Others
- Reimagine Care: AI-enabled care platform whose autonomous AI assistant Remi is deployed across partner community oncology practices including Tennessee Oncology. An enabling technology partner rather than a direct competitor, but its adoption trajectory will shape Tennessee Oncology's competitive positioning on patient experience and ED avoidance.
- Canopy (Canopy Health): AI phone operator ('Kathy') that handles incoming calls at community oncology practices including Tennessee Oncology peers. Enabling technology vendor that improves operational efficiency for community oncology; relevant for benchmarking Tennessee Oncology's tech adoption curve.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Tennessee Oncology social profiles
Digital presenceTennessee Oncology financial estimates
Financial estimateRevenue estimate
Valuation estimate
Tennessee Oncology leadership team
Management profileNumber of profiles
Profiles8 records
Tennessee Oncology subsidiaries and ownership
Company hierarchySubsidiaries2 records
Tennessee Oncology funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Tennessee Oncology M&A and investment
M&A and investmentM&A
Investments1 record
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Tennessee Oncology
What does Tennessee Oncology do?
Tennessee Oncology is a community-based cancer care practice that provides comprehensive cancer treatment and supportive services across 35+ clinic locations in Tennessee and North Georgia. Its offerings span medical oncology, hematology, radiation oncology, gynecologic oncology, cellular therapy, proton therapy, infusion therapy, diagnostic imaging, early-phase clinical trials, and ancillary support services such as genetic counseling, palliative care, psychosocial oncology, survivorship care, and on-site specialty pharmacy.
Is Tennessee Oncology a public or private company?
Tennessee Oncology is a private company. It is classified as unknown and is currently operating.
When was Tennessee Oncology founded?
Tennessee Oncology was founded in 1976. It employs 1,001 to 5,000 people.
Where is Tennessee Oncology based?
Tennessee Oncology is headquartered in Nashville, United States, in the North America region.
How does Tennessee Oncology make money?
One revenue line is on record: cancer Care Services.
Who are Tennessee Oncology's main competitors?
Direct peers on record are Florida Cancer Specialists & Research Institute, OneOncology, Sarah Cannon Research Institute, Highlands Oncology Group, Compass Oncology and New York Cancer & Blood Specialists. Broad incumbents are The US Oncology Network (McKesson) and Vanderbilt-Ingram Cancer Center. Others are Reimagine Care and Canopy (Canopy Health).
Does Tennessee Oncology have an API?
No public API is recorded for Tennessee Oncology.
What industry is Tennessee Oncology in?
Tennessee Oncology's product category is Oncology Care Services. Its primary akta.pro industry code is HLAKAFAB, Medical Oncology, with a secondary code of HLAKAFAC, Radiation Oncology. Its NAICS code is 62111 and its SIC code is 8011.